Israel Englander Annexon, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Annexon, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 72,655 shares of ANNX stock, worth $383,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,655
Previous 347,212
79.07%
Holding current value
$383,618
Previous $1.7 Million
74.72%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ANNX
# of Institutions
146Shares Held
102MCall Options Held
178KPut Options Held
159K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$44.6 Million8.98% of portfolio
-
Satter Management Co., L.P.7.41MShares$39.1 Million76.44% of portfolio
-
Bvf Inc San Francisco, CA7MShares$37 Million1.32% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$34.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$33.9 Million2.49% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $251M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...